RIANA Therapeutics
@rianatx.com
Our Mission We are developing innovative drugs to target challenging protein-protein interactions in cancer, leveraging our proprietary phenotypic drug discovery platform. Having successfully completed hit validation for our first program, we are now seeking seed investors to advance to the lead identification stage. Read more about our science and about our company. Our Science We…
RIANA Therapeutics's Company Logos
RIANA Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#313131
Mine Shaft
49, 49, 49
0, 0, 19
0, 0, 0, 81
#FAF9F9
Alabaster
250, 249, 249
0, 9, 98
0, 0, 0, 2
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
About RIANA Therapeutics
RIANA Therapeutics is a cutting-edge brand that aims to revolutionize cancer treatment through the development of novel anti-cancer therapies. As a spin-off from the University of Veterinary Medicine in Vienna, RIANA Therapeutics leverages academic findings to create groundbreaking therapeutics for cancer patients. The brand focuses on selectively targeting specific oncogenic protein-protein interactions (PPI) that have been challenging to address in drug discovery.
They have developed a unique cell-based phenotypic screening system that allows for the identification of inhibitors to disrupt these PPI. RIANA Therapeutics has successfully identified STAT5B oligomerization inhibitors, which represent a highly innovative approach to treating hematopoietic and other cancer types. By targeting oncogenic PPI, RIANA Therapeutics aims to develop potent and safe medicines with significantly fewer side effects while maintaining efficacy.
Located in Vienna, Austria, RIANA Therapeutics is at the forefront of advancing cancer therapies
Company type
Privately Held
Year founded
2023
Company size
2-10 employees
